Back
Madrigal Pharmaceuticals Vs. Matinas BioPharma Holdings Industry Stock Comparison
Buy
65
MDGL
Madrigal Pharmaceuticals
Last Price:
339.22
Seasonality Move:
35.27%
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
0.72
Seasonality Move:
10.35%
Buy
65
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $339.66. The Score for MDGL is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy, Sell or Hold?
- The current Matinas BioPharma Holdings [MTNB] share price is $0.90. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $339.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
MTNB Stock Price Chart
What is Matinas BioPharma Holdings's stock price today?
-
The Matinas BioPharma Holdings share price today is $0.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing slight buying pressure.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 33.93 | Buy |
| Relative Strength Index (14 RSI): | 78.94 | Buy |
| Chaikin Money Flow: | -276914 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (192.75 - 306.45) | Buy |
| Bollinger Bands (100): | (218.46 - 289.52) | Buy |
MTNB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.69 | Sell |
| Relative Strength Index (14 RSI): | 25.78 | Sell |
| Chaikin Money Flow: | 136142 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.14 - 3.74) | Sell |
| Bollinger Bands (100): | (-0.07 - 3.15) | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 328.92 | Buy |
| 20-day SMA: | 258.63 | Buy |
| 50-day SMA: | 239.12 | Buy |
| 200-day SMA: | 244.54 | Buy |
| 8-day EMA: | 321.73 | Buy |
| 20-day EMA: | 279.87 | Buy |
| 50-day EMA: | 254.01 | Buy |
| 200-day EMA: | 240.76 | Buy |
MTNB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.63 | Buy |
| 20-day SMA: | 2.24 | Sell |
| 50-day SMA: | 2.92 | Sell |
| 200-day SMA: | 0.87 | Buy |
| 8-day EMA: | 0.98 | Sell |
| 20-day EMA: | 1.78 | Sell |
| 50-day EMA: | 2.15 | Sell |
| 200-day EMA: | 1.23 | Sell |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.14 per share, and an increase next year of $9.75 per share.
Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and an increase next year of $1.35 per share.
Madrigal Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Matinas BioPharma Holdings Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||